Irrespective of the correlation between PRAME gene expression and all clinical parameters, the PRAME gene could be used as a potential marker for monitoring the malignancies with tumor-associated antigens (TAA) and leukemia-associated antigens (LAA) [16, 22]. The gene discussed is PRAME; the disease is neoplasm.